Hirotomo Kato

5.1k total citations
163 papers, 3.8k citations indexed

About

Hirotomo Kato is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, Hirotomo Kato has authored 163 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Public Health, Environmental and Occupational Health, 69 papers in Epidemiology and 35 papers in Immunology. Recurrent topics in Hirotomo Kato's work include Research on Leishmaniasis Studies (85 papers), Trypanosoma species research and implications (60 papers) and Insect symbiosis and bacterial influences (19 papers). Hirotomo Kato is often cited by papers focused on Research on Leishmaniasis Studies (85 papers), Trypanosoma species research and implications (60 papers) and Insect symbiosis and bacterial influences (19 papers). Hirotomo Kato collaborates with scholars based in Japan, Ecuador and Peru. Hirotomo Kato's co-authors include Yoshihisa Hashiguchi, Eduardo A. Gómez, Hiroshi Uezato, Tatsuyuki Mimori, Hiroyuki Iwata, Abraham G. Cáceres, Ken Katakura, Takashi Ohashi, Chukwunonso O. Nzelu and Mari Kannagi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Hirotomo Kato

158 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirotomo Kato Japan 33 1.7k 1.3k 809 535 499 163 3.8k
Sonja M. Best United States 36 1.9k 1.1× 926 0.7× 890 1.1× 586 1.1× 2.7k 5.3× 84 4.1k
Margo A. Brinton United States 44 3.1k 1.8× 673 0.5× 972 1.2× 1.4k 2.7× 3.2k 6.5× 120 6.2k
Chang S. Hahn United States 27 2.5k 1.4× 762 0.6× 734 0.9× 1.0k 1.9× 2.2k 4.3× 39 4.4k
Manuel A. Patarroyo Colombia 28 1.9k 1.1× 976 0.7× 1.1k 1.3× 1.4k 2.7× 742 1.5× 291 4.1k
Guey‐Chuen Perng United States 40 1.7k 1.0× 2.2k 1.6× 1.3k 1.7× 476 0.9× 1.6k 3.2× 118 4.5k
Laurence Briant France 36 2.1k 1.2× 854 0.6× 1.2k 1.5× 983 1.8× 1.9k 3.9× 83 4.8k
Joy Gardner Australia 33 1.4k 0.8× 532 0.4× 892 1.1× 574 1.1× 1.3k 2.7× 54 3.0k
Philippe Desprès France 40 4.2k 2.5× 1.1k 0.8× 1.0k 1.3× 848 1.6× 3.8k 7.7× 67 5.9k
Victor Stollar United States 38 2.4k 1.4× 639 0.5× 368 0.5× 1.4k 2.6× 2.4k 4.7× 108 4.5k

Countries citing papers authored by Hirotomo Kato

Since Specialization
Citations

This map shows the geographic impact of Hirotomo Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotomo Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotomo Kato more than expected).

Fields of papers citing papers by Hirotomo Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirotomo Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotomo Kato. The network helps show where Hirotomo Kato may publish in the future.

Co-authorship network of co-authors of Hirotomo Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Hirotomo Kato. A scholar is included among the top collaborators of Hirotomo Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirotomo Kato. Hirotomo Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Hirotomo. (2024). Epidemiology of Leishmaniasis: Risk factors for its pathology and infection. Parasitology International. 105. 102999–102999. 6 indexed citations
2.
Koike, Yuki, Takahiro Inoue, Hirotomo Kato, et al.. (2024). A novel chemokine binding protein 1-like gene is vital for the blood pool development and engorgement of the hard tick Haemaphysalis longicornis. Parasitology International. 104. 102990–102990.
4.
Yamamoto, Daisuke S., et al.. (2023). A rare sugar, allose, inhibits the development of Plasmodium parasites in the Anopheles mosquito independently of midgut microbiota. Frontiers in Cellular and Infection Microbiology. 13. 1162918–1162918.
5.
Itoh, Makoto, et al.. (2022). Development of a Highly Sensitive Nested PCR and Its Application for the Diagnosis of Cutaneous Leishmaniasis in Sri Lanka. Microorganisms. 10(5). 990–990. 13 indexed citations
7.
Kato, Hirotomo, et al.. (2017). First identification of L. major in a dog in an endemic area of human cutaneous leishmaniasis in Iraq: molecular and phylogenetic studies. Parasitology Research. 117(2). 585–590. 10 indexed citations
8.
Hashiguchi, Yoshihisa, et al.. (2016). Leishmaniases in Ecuador: Comprehensive review and current status. Acta Tropica. 166. 299–315. 31 indexed citations
9.
Kato, Hirotomo, et al.. (2014). Sand Fly Fauna (Diptera, Pcychodidae, Phlebotominae) in Different Leishmaniasis-Endemic Areas of Ecuador, Surveyed Using a Newly Named Mini-Shannon Trap. Tropical Medicine and Health. 42(4). 163–170. 9 indexed citations
10.
Kato, Hirotomo, Eduardo A. Gómez, Abraham G. Cáceres, et al.. (2010). Natural Infections of Man-Biting Sand Flies by Leishmania and Trypanosoma Species in the Northern Peruvian Andes. Vector-Borne and Zoonotic Diseases. 11(5). 515–521. 24 indexed citations
11.
Kato, Hirotomo, Kohtaro Fujihashi, Rie Kato, Yoshikazu Yuki, & Jerry R. McGhee. (2001). Oral Tolerance Revisited: Prior Oral Tolerization Abrogates Cholera Toxin-Induced Mucosal IgA Responses. The Journal of Immunology. 166(5). 3114–3121. 42 indexed citations
12.
Kannagi, Mari, Takashi Ohashi, Shino Hanabuchi, et al.. (2000). Immunological Aspects of Rat Models of HTLV Type 1-Infected T Lymphoproliferative Disease. AIDS Research and Human Retroviruses. 16(16). 1737–1740. 18 indexed citations
13.
Koga, Toshiya, Jerry R. McGhee, Hirotomo Kato, et al.. (2000). Evidence For Early Aging in the Mucosal Immune System. The Journal of Immunology. 165(9). 5352–5359. 80 indexed citations
14.
Enjyoji, Keiichi, Koichi Kokame, S. Nakamura, et al.. (1999). Monkey Hepatocytes Efficiently Express Tissue Factor Pathway Inhibitor (TFPI), in Contrast with Human and Rat Hepatocytes. The Journal of Biochemistry. 125(6). 1039–1047. 1 indexed citations
15.
Ohashi, Takashi, Masaaki Arai, Hirotomo Kato, et al.. (1998). High SDF-1 Expression in HIV-1 Carriers Does Not Correlate with CD8+T-Cell-Mediated Suppression of Viral Replication. Virology. 244(2). 467–472. 11 indexed citations
16.
Kato, Hirotomo, Tomoyuki Tahara, Takashi Kato, et al.. (1998). Molecular cloning and functional expression of feline thrombopoietin. Veterinary Immunology and Immunopathology. 66(3-4). 225–236. 1 indexed citations
17.
Kato, Hirotomo, et al.. (1997). Molecular cloning and functional expression of equine interleukin-1 receptor antagonist. Veterinary Immunology and Immunopathology. 56(3-4). 221–231. 14 indexed citations
18.
Kato, Hirotomo, Takashi Ohashi, Noriko Nakamura, et al.. (1995). Molecular cloning of equine interleukin-1alpha and -beta cDNAs. Diabetes Research and Clinical Practice. 29(1). 221–231. 1 indexed citations
19.
Kato, Hirotomo, Naoshige Uchida, T. Ishida, & Kazuro Sugimura. (1995). A unified model for cell-killing by heat: Interpretation of continuous, step-down, step-up and split heating. Medical Hypotheses. 45(1). 11–14. 2 indexed citations
20.
Kato, Hirotomo. (1951). Studies on flavone glycoside “Rutin”. Folia Pharmacologica Japonica. 47(3-4). 93–102,en7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026